405 related articles for article (PubMed ID: 37190507)
1. Exploring Monocytes-Macrophages in Immune Microenvironment of Glioblastoma for the Design of Novel Therapeutic Strategies.
Caverzán MD; Beaugé L; Oliveda PM; Cesca González B; Bühler EM; Ibarra LE
Brain Sci; 2023 Mar; 13(4):. PubMed ID: 37190507
[TBL] [Abstract][Full Text] [Related]
2. Tumor-associated microglia and macrophages in glioblastoma: From basic insights to therapeutic opportunities.
Wang G; Zhong K; Wang Z; Zhang Z; Tang X; Tong A; Zhou L
Front Immunol; 2022; 13():964898. PubMed ID: 35967394
[TBL] [Abstract][Full Text] [Related]
3. Macrophages and microglia in glioblastoma: heterogeneity, plasticity, and therapy.
Khan F; Pang L; Dunterman M; Lesniak MS; Heimberger AB; Chen P
J Clin Invest; 2023 Jan; 133(1):. PubMed ID: 36594466
[TBL] [Abstract][Full Text] [Related]
4. Current perspectives on diffuse midline glioma and a different role for the immune microenvironment compared to glioblastoma.
Pachocki CJ; Hol EM
J Neuroinflammation; 2022 Nov; 19(1):276. PubMed ID: 36403059
[TBL] [Abstract][Full Text] [Related]
5. Glioblastoma genetic drivers dictate the function of tumor-associated macrophages/microglia and responses to CSF1R inhibition.
Rao R; Han R; Ogurek S; Xue C; Wu LM; Zhang L; Zhang L; Hu J; Phoenix TN; Waggoner SN; Lu QR
Neuro Oncol; 2022 Apr; 24(4):584-597. PubMed ID: 34562087
[TBL] [Abstract][Full Text] [Related]
6. Harnessing the cross-talk between tumor cells and tumor-associated macrophages with a nano-drug for modulation of glioblastoma immune microenvironment.
Li TF; Li K; Wang C; Liu X; Wen Y; Xu YH; Zhang Q; Zhao QY; Shao M; Li YZ; Han M; Komatsu N; Zhao L; Chen X
J Control Release; 2017 Dec; 268():128-146. PubMed ID: 29051064
[TBL] [Abstract][Full Text] [Related]
7. Interactions between tumor-associated macrophages and tumor cells in glioblastoma: unraveling promising targeted therapies.
Morisse MC; Jouannet S; Dominguez-Villar M; Sanson M; Idbaih A
Expert Rev Neurother; 2018 Sep; 18(9):729-737. PubMed ID: 30099909
[TBL] [Abstract][Full Text] [Related]
8. The diversity and dynamics of tumor-associated macrophages in recurrent glioblastoma.
Zhang L; Jiang Y; Zhang G; Wei S
Front Immunol; 2023; 14():1238233. PubMed ID: 37731483
[TBL] [Abstract][Full Text] [Related]
9. Monocyte-neutrophil entanglement in glioblastoma.
Friedmann-Morvinski D; Hambardzumyan D
J Clin Invest; 2023 Jan; 133(1):. PubMed ID: 36594465
[TBL] [Abstract][Full Text] [Related]
10. Macrophages and microglia: the cerberus of glioblastoma.
Buonfiglioli A; Hambardzumyan D
Acta Neuropathol Commun; 2021 Mar; 9(1):54. PubMed ID: 33766119
[TBL] [Abstract][Full Text] [Related]
11. Microglia/Brain Macrophages as Central Drivers of Brain Tumor Pathobiology.
Gutmann DH; Kettenmann H
Neuron; 2019 Nov; 104(3):442-449. PubMed ID: 31697921
[TBL] [Abstract][Full Text] [Related]
12. The Association between Tumor-associated Macrophages and Glioblastoma: A Potential Target for Therapy.
Heidari A; Sharif PM; Rezaei N
Curr Pharm Des; 2021; 27(46):4650-4662. PubMed ID: 34397322
[TBL] [Abstract][Full Text] [Related]
13. Tumor-Associated Macrophages in Gliomas-Basic Insights and Treatment Opportunities.
Andersen JK; Miletic H; Hossain JA
Cancers (Basel); 2022 Mar; 14(5):. PubMed ID: 35267626
[TBL] [Abstract][Full Text] [Related]
14. Intravital 2-photon imaging reveals distinct morphology and infiltrative properties of glioblastoma-associated macrophages.
Chen Z; Ross JL; Hambardzumyan D
Proc Natl Acad Sci U S A; 2019 Jul; 116(28):14254-14259. PubMed ID: 31235603
[TBL] [Abstract][Full Text] [Related]
15. Dual role of ARPC1B in regulating the network between tumor-associated macrophages and tumor cells in glioblastoma.
Liu T; Zhu C; Chen X; Wu J; Guan G; Zou C; Shen S; Chen L; Cheng P; Cheng W; Wu A
Oncoimmunology; 2022; 11(1):2031499. PubMed ID: 35111386
[TBL] [Abstract][Full Text] [Related]
16. Role of myeloid cells in the immunosuppressive microenvironment in gliomas.
Locarno CV; Simonelli M; Carenza C; Capucetti A; Stanzani E; Lorenzi E; Persico P; Della Bella S; Passoni L; Mavilio D; Bonecchi R; Locati M; Savino B
Immunobiology; 2020 Jan; 225(1):151853. PubMed ID: 31703822
[TBL] [Abstract][Full Text] [Related]
17. Glioblastoma-instructed microglia transition to heterogeneous phenotypic states with phagocytic and dendritic cell-like features in patient tumors and patient-derived orthotopic xenografts.
Yabo YA; Moreno-Sanchez PM; Pires-Afonso Y; Kaoma T; Nosirov B; Scafidi A; Ermini L; Lipsa A; Oudin A; Kyriakis D; Grzyb K; Poovathingal SK; Poli A; Muller A; Toth R; Klink B; Berchem G; Berthold C; Hertel F; Mittelbronn M; Heiland DH; Skupin A; Nazarov PV; Niclou SP; Michelucci A; Golebiewska A
bioRxiv; 2023 Dec; ():. PubMed ID: 36945572
[TBL] [Abstract][Full Text] [Related]
18. Cellular and Molecular Identity of Tumor-Associated Macrophages in Glioblastoma.
Chen Z; Feng X; Herting CJ; Garcia VA; Nie K; Pong WW; Rasmussen R; Dwivedi B; Seby S; Wolf SA; Gutmann DH; Hambardzumyan D
Cancer Res; 2017 May; 77(9):2266-2278. PubMed ID: 28235764
[TBL] [Abstract][Full Text] [Related]
19. Immune Microenvironment in Glioblastoma Subtypes.
Chen Z; Hambardzumyan D
Front Immunol; 2018; 9():1004. PubMed ID: 29867979
[TBL] [Abstract][Full Text] [Related]
20. Targeting glioblastoma with NK cells and mAb against NG2/CSPG4 prolongs animal survival.
Poli A; Wang J; Domingues O; Planagumà J; Yan T; Rygh CB; Skaftnesmo KO; Thorsen F; McCormack E; Hentges F; Pedersen PH; Zimmer J; Enger PØ; Chekenya M
Oncotarget; 2013 Sep; 4(9):1527-46. PubMed ID: 24127551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]